Skip to main content

Medical materials

Publication
  • HTRS
  • 16 March, 2025

SYNOVIIIUS: Prospective Interventional Study of Effectiveness of Efanesoctocog Alfa Prophylaxis on Synovial Hypertrophy in Patients with Hemophilia A — Study Design

Davide Matino, Jennifer Dumont, Annemieke Willemze, Abhimanyu Yarramaneni, Elena Santagostino, Claude Négrier, Nicole Tsao

Available materials

Publication
  • HTRS
  • 15 March, 2025

Clinical Outcomes Over 3 Years of Once-Weekly Efanesoctocog Alfa Treatment in Adults and Adolescents from North America with Severe Hemophilia A in the Phase 3 XTEND-ed Long-Term Extension Study

Janice Staber, Angela Weyand, Umer Khan, Jennifer Dumont, Lara Mamikonian, Davide Matino

Available materials

Publication
  • HTRS
  • 15 March, 2025

Clinical Outcomes Over 2 Years of Once-Weekly Efanesoctocog Alfa Treatment in Children From North America With Severe Hemophilia A in the Phase 3 XTEND-ed Long-Term Extension Study

Lynn Malec, Mindy Simpson, Umer Khan, Graham Neill, Lara Mamikonian, Cristina Tarango

Available materials

Publication
  • HTRS
  • 15 March, 2025

Efanesoctocog Alfa for the Perioperative Management of Patients with Severe Hemophilia A: 4 Years of Experience in the XTEND Clinical Program in North America

Annette von Drygalski, Anthony KC Chan, Jennifer Dumont, Lara Mamikonian, Umer Khan, Amy Dunn

Available materials

Sign up for alerts